People: Inovio Pharmaceuticals Inc (INO.A)

INO.A on American Stock Exchange

0.71USD
3:59pm EDT
Price Change (% chg)

$0.03 (+4.34%)
Prev Close
$0.68
Open
$0.69
Day's High
$0.72
Day's Low
$0.68
Volume
218,747
Avg. Vol
192,204
52-wk High
$0.83
52-wk Low
$0.38

Search Stocks

Cabrera, Angel 

Brief Biography

Dr. Angel Cabrera, Ph.D., has been appointed as Director of Inovio Pharmaceuticals, Inc., effective June 15, 2012. Dr. Cabrera is outgoing president of the Thunderbird School of Global Management, regarded as the world's graduate school of international business. On July 1, Dr. Cabrera will become president of George Mason University, the university in Virginia. During his eight-year term, Dr. Cabrera led a academic, operational and financial overhaul of the international business school, stemming operating deficits and declining revenues and consolidating Thunderbird's leadership position in the global business educational arena. Prior to Thunderbird, Cabrera served as Dean of IE Business School in Madrid, which he helped propel into the top tier of international business schools. Prior to IE he was a change management consultant with Accenture. Angel Cabrera earned his Ph.D. and M.S. in psychology and cognitive science from the Georgia Institute of Technology which he attended as a Fulbright Scholar and his B.S. and M.S. in computer and electrical engineering from Madrid's Polytechnic University, Spain's premier engineering school. He received additional training in cognitive science at Carnegie Mellon University and in global leadership at the Harvard Kennedy School. He has published in fields ranging from learning technology to psychology, management and higher education. His most recent book, "Being Global: How to Think, Act and Lead in a Transformed World," was recently published by Harvard Business Review Press. Dr. Cabrera is an advocate of corporate social responsibility and managerial professionalism.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Avtar Dhillon

657,202

J. Joseph Kim

903,597

Peter Kies

453,440

Niranjan Sardesai

459,760

Mark Bagarazzi

444,965

Angel Cabrera

--
As Of 30 Dec 2011
Search Stocks